IN-DATE
RS-24L: Endocare 2.4mm Long Shaft RenalCryo Probe, Oblong Ice
Sign in to add this product to your favorites!
| Price: | $117.00 $11.70 EACH |
|---|---|
| Quantity: | |
| In Stock: | 4 eaches |
| Status: | expired |
AccessGUDID Info
- FDA Product Code: GEH
- FDA Product Code Name: Unit, Cryosurgical, Accessories
- GMDN Term Code: 45140
- GMDN Term Name: Cryosurgical set
- GMDN Term Description: A sterile collection of disposable devices used in conjunction with a cryosurgical unit as well as monitoring and other devices to perform a surgical technique that involves freezing a targeted area of tissue to damage and destroy cancer cells in the unwanted portions. A typical set will contain cryo needles, thermal sensors, warmer tubes and catheters, warmer cassette, and tube holders. It is typically used for early stages of prostate cancer or late recurrence of localized prostate cancer after radiotherapy where the prostate is cooled to a temperature of -40° Celsius. Warming of the areas where freezing is not required is simultaneously carried out. This is a single-use device.
More on Ablation | Cryo
Cryoablation is a catheter-based technique used to treat atrial fibrillation by applying extreme cold to targeted areas of heart tissue. This freezing process creates scar tissue that blocks the abnormal electrical signals responsible for triggering arrhythmia. Unlike heat-based methods like radiofrequency ablation, cryoablation uses a balloon catheter to deliver cold energy in a more uniform, circumferential manner—often around the pulmonary veins. The approach is valued for its procedural consistency, controlled lesion formation, and lower risk of certain complications, making it a widely used option in the treatment of AF.
Manufacturer
Varian, a Siemens Healthineers company, is a global leader in cancer care technologies, specializing in advanced solutions for radiation oncology and interventional oncology. With a mission to create a world without fear of cancer, Varian offers innovative systems and software designed to improve the precision and effectiveness of cancer treatment.
Their portfolio includes state-of-the-art linear accelerators like the TrueBeam® and Halcyon® systems, which deliver precise radiotherapy and radiosurgery treatments. Additionally, Varian provides advanced treatment planning software such as Eclipse™ and patient management solutions like ARIA® to streamline workflows and enhance care delivery.
By combining cutting-edge technology with a commitment to improving patient outcomes, Varian empowers healthcare providers to deliver life-saving cancer treatments with accuracy and confidence.
